Lazo-Langner A, Louzada M, Garg A, et al. Assessing the risk-benefit of anticoagulants in elkderly patients with cancer-associated venous thromboembolism; a population based study. EHA 2017, abstract S441.
Verlengde behandeling met apixaban bij uitgelokte VTE met permanente risicofactoren
okt 2025 | Benigne hematologie